Related Experiment Videos
Analogous enzymes: independent inventions in enzyme evolution
M Y Galperin1, D R Walker, E V Koonin
1National Center for Biotechnology Information (NCBI), National Library of Medicine, National Institutes of Health, Bethesda, Maryland 20894, USA.
Genome Research
|September 2, 1998
Summary
Researchers discovered analogous enzymes, which are structurally unrelated proteins catalyzing the same reaction. This finding highlights convergent evolution in enzymes and suggests new antibacterial drug targets.
Area of Science:
- Biochemistry
- Enzymology
- Evolutionary Biology
Background:
- The same biochemical reaction can be catalyzed by enzymes with different protein structures.
- Homologous enzymes share evolutionary origins, while analogous enzymes do not necessarily.
Purpose of the Study:
- To systematically search for analogous enzymes across different enzyme classes.
- To investigate the evolutionary origins and distribution of analogous enzymes.
- To explore the potential of analogous enzymes as drug targets.
Main Methods:
- Systematic search for analogous enzymes using sequence conservation analysis.
- Evaluation of enzymes sharing the same Enzyme Commission (EC) number.
- Utilizing sensitive, iterative sequence database search methods.
- Structural fold comparison to confirm independent evolutionary origins.
Main Results:
- Identified analogous enzymes for 105 EC numbers, involving 243 distinct proteins.
- Confirmed independent evolutionary origins for 34 cases by distinct structural folds.
- Found analogous enzymes across all enzyme classes, with patchy distribution in biochemical pathways.
- Observed differences between bacterial and eukaryotic forms of analogous enzymes.
Conclusions:
- Convergent evolution is a significant factor in enzyme evolution, leading to analogous enzymes.
- The patchy distribution suggests gene transfer and selective loss events shaped enzyme repertoires.
- Recruitment of enzymes with similar but distinct functions is a key evolutionary scenario.
- Bacterial and eukaryotic analogous enzymes represent potential targets for novel antibacterial drug development.